Tag: WHO

WHO Calls on Countries to Scale Up Investments in Eliminating Hepatitis

who
Ahead of World Hepatitis Day (28 July), WHO calls on countries to take advantage of recent reductions in the costs of diagnosing and treating viral hepatitis and scale up investments in disease el...

WHO Revised Guidance on QMS for National GMP Inspectorates

The World Health Organization (WHO) has revised its guidance on quality system requirements for national good manufacturing practice (GMP) inspectorates to align with international standards and the l...

WHO Recommended Use of Dolutegravir as Preferred HIV Treatment Option

Based on new evidence assessing benefits and risks, the WHO recommends the use of the HIV drug dolutegravir (DTG) as the preferred first-line and second-line treatment for all populations, including p...

Global Guidance on Medicines and Diagnostic Tests Updated by WHO

WHO’s Essential Medicines List and List of Essential Diagnostics are core guidance documents that help countries prioritize critical health products that should be widely available and affordable thro...

WHO Updated Lists of Essential Medicines and Diagnostics

who
WHO’s Essential Medicines List and List of Essential Diagnostics are core guidance documents that help countries prioritize critical health products that should be widely available and affordable thro...

Cholera Vaccination Campaign Continues in the DR Congo

Phase 2 of the biggest ever oral vaccination campaign against cholera is scheduled to take place from 3-8 July 2019 in 15 health districts in the four central provinces of the Democratic Republic of t...

Some Valsartan Versions May Contain New Cancer-Causing Impurity

Online pharmacy Valisure reported that it found a new cancer-causing impurity in some versions of widely prescribed blood pressure medicine valsartan, but U.S. regulators said on Tuesday that the amou...

WHO Urges to Use New Antimicrobial Resistance Tool

who
WHO launched a global campaign urging governments to adopt a tool to reduce the spread of antimicrobial resistance, adverse events and costs. The AWaRe tool was developed by the WHO Essential Medic...

Measures for Lowering Medicine Prices in Russia Showed to Be Effective

In 2010, Professor Liliya Ziganshina (Head of Cochrane Russia), one of the co-authors of the paper, partook in a study on access to medicines with expert advice and methodology support from the World ...

Prevalence and Incidence of Four Curable Sexually Transmitted Infections Remain High

who
The prevalence and incidence of four curable sexually transmitted infections (STIs) –chlamydia, gonorrhoea, trichomoniasis, and syphilis – remain high according to global estimates, with over one mill...

WHO Published Draft Document on “Environmental Aspects of GMP”

who
The World Health Organization has published a draft document on "Environmental Aspects of GMP: points to consider for manufacturers and inspectors in the prevention of antimicrobial resistance". Wi...

WHO Announces New Draft for GDP Guidelines

The World Health Organization (WHO) plans to revise its Good Storage and Distribution Practice guidelines. During the 53. WHO Expert Committee on Specifications for Pharmaceutical Preparations (ECSPP;...

WHO Launched Health Product Profile Directory Tool

WHO’s new Science Division launched an online resource to guide the development of new health products for which there are limited markets or incentives for research and development. An essential tool...

New Technology for Malaria Treatment Developed in China

Chinese researchers have developed a new technology to produce artemisinin, the top choice for malaria treatment, on a large scale. Sweet wormwood was used in ancient Chinese therapy to treat vario...

WHO Changes Strategy in DRC Due to Unstable Merck Ebola Vaccine Supply

who
WHO’s Strategic Advisory Group of Experts (SAGE) today issued new recommendations to address vaccination challenges in the ongoing Ebola outbreak in the Democratic Republic of the Congo (DRC). The ...

World’s First Point-of-Care HIV Test Received WHO PQ Approval

Abbott announced that m-PIMA™ HIV-1/2 VL, the world's first point-of-care viral load diagnostic test, has received the World Health Organization's Prequalification approval (WHO PQ). The test received...